Cargando…
Shared decision-making in advanced kidney disease: a scoping review protocol
INTRODUCTION: Patients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality deci...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050317/ https://www.ncbi.nlm.nih.gov/pubmed/32111615 http://dx.doi.org/10.1136/bmjopen-2019-034142 |
_version_ | 1783502603255021568 |
---|---|
author | Engels, Noel de Graav, Gretchen van der Nat, Paul van den Dorpel, Marinus Bos, Willem Jan Stiggelbout, Anne M |
author_facet | Engels, Noel de Graav, Gretchen van der Nat, Paul van den Dorpel, Marinus Bos, Willem Jan Stiggelbout, Anne M |
author_sort | Engels, Noel |
collection | PubMed |
description | INTRODUCTION: Patients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality decisions that align with their values and preferences. However, systematic reviews or scoping reviews on these SDM interventions and on their reported use or outcomes are lacking. This limits the adoption of SDM in clinical practice and hampers further research and development on the subject. Our aim is to provide a comprehensive and up-to-date overview of these SDM interventions by means of a scoping review of the literature. Scoping reviews can provide a broad overview of a topic, identify gaps in the research knowledge base and report on the types of evidence that address and inform practices. This paper presents our study protocol. METHODS AND ANALYSIS: The proposed scoping review will be performed in accordance with the Joanna Briggs Institute’s (JBI) methodology for scoping reviews. It will cover both qualitative and quantitative scientific literature, as well as the grey literature on SDM interventions for treatment modality decisions in AKD. Only literature written in English will be considered for inclusion. Two independent reviewers will participate in an iterative process of screening the literature, paper selection and data extraction. Disagreements between the reviewers will be resolved by discussion until consensus is reached or after consultation with the research team when needed. Results will be reported with descriptive statistics and diagrammatic or tabular displayed information, accompanied by narrative summaries as explained in the JBI guidelines. ETHICS AND DISSEMINATION: Ethical approval for the conduct of this study is not required. We will analyse previously collected data for the proposed scoping review. Our results will be published in a peer-reviewed journal and disseminated through conferences and/or seminars. |
format | Online Article Text |
id | pubmed-7050317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-70503172020-03-16 Shared decision-making in advanced kidney disease: a scoping review protocol Engels, Noel de Graav, Gretchen van der Nat, Paul van den Dorpel, Marinus Bos, Willem Jan Stiggelbout, Anne M BMJ Open Renal Medicine INTRODUCTION: Patients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality decisions that align with their values and preferences. However, systematic reviews or scoping reviews on these SDM interventions and on their reported use or outcomes are lacking. This limits the adoption of SDM in clinical practice and hampers further research and development on the subject. Our aim is to provide a comprehensive and up-to-date overview of these SDM interventions by means of a scoping review of the literature. Scoping reviews can provide a broad overview of a topic, identify gaps in the research knowledge base and report on the types of evidence that address and inform practices. This paper presents our study protocol. METHODS AND ANALYSIS: The proposed scoping review will be performed in accordance with the Joanna Briggs Institute’s (JBI) methodology for scoping reviews. It will cover both qualitative and quantitative scientific literature, as well as the grey literature on SDM interventions for treatment modality decisions in AKD. Only literature written in English will be considered for inclusion. Two independent reviewers will participate in an iterative process of screening the literature, paper selection and data extraction. Disagreements between the reviewers will be resolved by discussion until consensus is reached or after consultation with the research team when needed. Results will be reported with descriptive statistics and diagrammatic or tabular displayed information, accompanied by narrative summaries as explained in the JBI guidelines. ETHICS AND DISSEMINATION: Ethical approval for the conduct of this study is not required. We will analyse previously collected data for the proposed scoping review. Our results will be published in a peer-reviewed journal and disseminated through conferences and/or seminars. BMJ Publishing Group 2020-02-27 /pmc/articles/PMC7050317/ /pubmed/32111615 http://dx.doi.org/10.1136/bmjopen-2019-034142 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Renal Medicine Engels, Noel de Graav, Gretchen van der Nat, Paul van den Dorpel, Marinus Bos, Willem Jan Stiggelbout, Anne M Shared decision-making in advanced kidney disease: a scoping review protocol |
title | Shared decision-making in advanced kidney disease: a scoping review protocol |
title_full | Shared decision-making in advanced kidney disease: a scoping review protocol |
title_fullStr | Shared decision-making in advanced kidney disease: a scoping review protocol |
title_full_unstemmed | Shared decision-making in advanced kidney disease: a scoping review protocol |
title_short | Shared decision-making in advanced kidney disease: a scoping review protocol |
title_sort | shared decision-making in advanced kidney disease: a scoping review protocol |
topic | Renal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050317/ https://www.ncbi.nlm.nih.gov/pubmed/32111615 http://dx.doi.org/10.1136/bmjopen-2019-034142 |
work_keys_str_mv | AT engelsnoel shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol AT degraavgretchen shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol AT vandernatpaul shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol AT vandendorpelmarinus shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol AT boswillemjan shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol AT stiggelboutannem shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol |